Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Cancer diagnosis stories

Nov 12, 2026

American Cancer Society revises guidelines to recommend routine PSA screening

The American Cancer Society issued a major guideline change recommending routine prostate cancer screening for men aged 50–69 at average risk, saying benefits now outweigh potential harms. This is the first update to its prostate cancer screening guidance in more than a decade.

Nov 12, 2026·5 sources
00
Nov 4, 2026

NHS England to roll out multi-cancer blood tests to 200 GP surgeries

New blood tests designed to detect multiple cancers simultaneously will be offered to NHS patients in approximately 200 GP surgeries in England as part of an expanded pilot program.

Nov 4, 2026·2 sources
00
Oct 30, 2026

NHS Wales faces critical radiologist shortage as cancer patients deteriorate waiting for scans

The Royal College of Radiologists reports NHS Wales has 88 fewer radiologists than needed—a 28% shortfall—and is seeing patients' conditions deteriorate while waiting for diagnostic scans for the first time. Cancer patients warn that delays in scans could mean the difference between life and death.

Oct 30, 2026·4 sources
00

PinkDx vaginal swab test could detect endometrial cancer without painful biopsy

A new vaginal swab test developed by molecular diagnostics company PinkDx may help women with abnormal bleeding detect endometrial cancer without undergoing a painful biopsy. The development comes as death rates from endometrial cancer, one of the most common cancers in women, are increasing.

Oct 30, 2026·5 sources
00
Oct 29, 2026

Northwestern Medicine develops liquid biopsy blood test for small cell lung cancer

Northwestern Medicine scientists have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer, according to a study published in the Journal of Clinical Investigation. The approach could eventually allow for better tracking and monitoring of this aggressive cancer type.

Oct 29, 2026·2 sources
00
Oct 27, 2026

Mayo Clinic study finds cerebrospinal fluid liquid biopsy detects brain tumor DNA

A Mayo Clinic study published in the Journal of Neuro-Oncology demonstrates that analyzing DNA in cerebrospinal fluid can provide diagnostic information for brain tumors when MRI imaging is unclear or tissue biopsy is difficult or unsafe to obtain.

Oct 27, 2026·2 sources
00
Oct 26, 2026

Fewer US men diagnosed with low-risk prostate cancer as surveillance replaces treatment

An analysis published in CANCER reveals a broad shift away from overtreatment of low-risk prostate cancer in the United States, with more men choosing surveillance over immediate treatment in response to concerns about overdiagnosis and overtreatment.

Oct 26, 2026·1 source
00
Oct 23, 2026

Diagnostic test could help doctors refine prostate cancer treatment with abiraterone

A novel diagnostic test could enable doctors to identify which prostate cancer patients would benefit from more intensive treatment with drugs like abiraterone, while sparing others from unnecessary side effects. The test aims to address the challenge of tailoring treatment for prostate cancer, which affects over 1 million men worldwide and behaves differently in each patient.

Oct 23, 2026·5 sources
00
Oct 21, 2026

OpenAI and Peter Thiel's Founders Fund invest in Coherence Neuro's cancer-detecting brain implant

Coherence Neuro has raised $45 million in funding from OpenAI's venture capital arm and Founders Fund to develop a brain implant designed to detect and treat cancer. The coin-sized device monitors tumor activity through neural signals.

Oct 21, 2026·2 sources
00
Oct 19, 2026

AI device successfully triages 94% of urgent skin cancer referrals in real-world hospital study

An autonomous AI medical device was successfully integrated into a real-world health system and managed 94% of urgent suspected skin cancer referrals, according to research presented at the European Academy of Dermatology and Venerology Congress. The device also safely discharged patients, demonstrating practical clinical application of AI in dermatology triage.

Oct 19, 2026·2 sources
00
Oct 16, 2026

Texas mother's severe pregnancy heartburn misdiagnosed, later revealed as stage 3 colon cancer

Geraldine Levano, 31, of Houston experienced severe acid reflux during her second pregnancy that doctors dismissed as pregnancy-related. The unbearable symptoms were later diagnosed as stage 3 colon cancer, highlighting the dangers of dismissing persistent or severe symptoms during pregnancy.

Oct 16, 2026·2 sources
00
Aug 4, 2026

FDA Grants 510(k) Clearance to DeepHealth's AI-Powered Breast Ultrasound Analysis Platform

DeepHealth, a RadNet subsidiary, received FDA 510(k) clearance for an AI platform that automates breast ultrasound lesion detection, characterization according to ACR BI-RADS standards, and report generation. The technology aims to address the time-intensive, operator-dependent nature of ultrasound breast cancer screening.

Aug 4, 2026·7 sources
00

UK breast cancer screening guidelines miss 95% of women under 50 who develop disease, study finds

Research from University of Cambridge and Institute of Cancer Research reveals that current NHS and NICE referral criteria fail to identify up to 95% of women under 50 who develop breast cancer within a decade. The study suggests a comprehensive risk assessment tool called BOADICEA identifies eight times more at-risk women than current family-history-based guidelines.

Aug 4, 2026·8 sources
00
Jul 23, 2026

Advanced Testing Methods Show Promise in Detecting Lung Cancer Biomarkers and Monitoring Disease

New research demonstrates that RNA-based testing can improve detection of MET exon 14 skipping mutations in lung cancer patients, while circulating tumor DNA (ctDNA) testing is increasingly being adopted for early cancer detection and treatment monitoring across oncology.

Jul 23, 2026·2 sources
00
May 30, 2026

DNA Test Could Allow Millions of Breast Cancer Patients to Safely Avoid Chemotherapy

Scientists have developed a DNA test that can distinguish between breast cancer patients who are likely to benefit from chemotherapy and those who can safely avoid it, potentially sparing millions from unnecessary treatment.

May 30, 2026·1 source
00
Apr 21, 2026

Blood Test Detects Aggressive Brain Tumors Early and Could Reduce Need for Risky Surgery

University of Sussex researchers, in collaboration with international scientists, identified a blood test capable of early diagnosis of the most aggressive form of brain cancer, potentially eliminating the need for dangerous surgical biopsies.

Apr 21, 2026·1 source
00

Top claims

  • ▪Black men face a 67% higher incidence rate of prostate cancer and nearly double the mortality rate compared with white men in the United States
  • ▪The U.S. Preventive Services Task Force recommends individualized decision-making for PSA screening rather than routine population screening, but announced an upcoming update to its guidelines
  • ▪The 2026 American Cancer Society guidelines recommend annual PSA screening starting at age 45 for men with a significant family history of prostate cancer

People involved

Peter Thiel

Subtopics

Cancer & Oncology11Drug Policy, Pricing & Approval6Drug Approval and Clinical Trials5Early cancer detection5AI in healthcare4Cancer4Cancer treatment4Cancer research3Diagnostic medicine3Oncology3Precision medicine3Women's health3Cancer prevention2Cancer Types2Clinical guidelines2Clinical trials2Diagnostic imaging2Radiology2Screening programs2AI standards, audits, and compliance1Biomarkers & bloodwork testing1Biotech startup1Brain health & dementia researchers1Brain-computer interfaces1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories